These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 573920)

  • 1. Development of factor VIII antibody in haemophilic monozygotic twins. European Study Group of Factor VIII Antibody.
    Scand J Haematol; 1979 Jul; 23(1):64-8. PubMed ID: 573920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic control by the HLA region of the immune response to factor VIII in hemophilic patients].
    Nuñez-Roldan A; Arnaiz-Villena A; Nuñez-Ollero G
    C R Seances Acad Sci D; 1979 Jun; 288(23):1719-20. PubMed ID: 114335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response induced by porcine factor VIII in severe hemophiliacs with antibody to F VIII.
    Verroust F; Allain JP
    Thromb Haemost; 1982 Oct; 48(2):238. PubMed ID: 6817447
    [No Abstract]   [Full Text] [Related]  

  • 4. The suppression of factor VIII antibodies in haemophilia.
    Dormandy KM; Sultan Y
    Pathol Biol (Paris); 1975 Dec; 23 suppl():17-23. PubMed ID: 772555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of homologous (canine/anti-canine) antibodies in dogs with haemophilia A (factor VIII deficiency): a ten-year longitudinal study.
    Tinlin S; Webster S; Giles AR
    Thromb Haemost; 1993 Jan; 69(1):21-4. PubMed ID: 8446933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired haemophilia: functional study of antibodies to Factor VIII.
    Allain JP; Gaillandre A; Frommel D
    Thromb Haemost; 1981 Jun; 45(3):285-9. PubMed ID: 6792741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA antigens and factor VIII antibody in classic hemophilia. European study group of factor VIII antibody.
    Frommel D; Allain JP; Saint-Paul E; Bosser C; Noël B; Mannucci PM; Pannicucci F; Blombäck M; Prou-Wartelle O; Muller JY
    Thromb Haemost; 1981 Dec; 46(4):687-9. PubMed ID: 6800049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of treatment with activated prothrombin complex concentrate (FEIBA) on factor VIII-antibody level.
    Lechner K; Nowotny C; Krinninger B; Zegner M; Deutsch E
    Thromb Haemost; 1979 Feb; 40(3):478-85. PubMed ID: 425062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary experience with achieving immune tolerance in patients with hemophilia A and circulating factor VIII inhibitor].
    Scharf R; Kucharski W; Lopaciuk S; Celińska W; Dmytrow A; Domański K; Gonet S; Miastkowski Z; Nowakowska I; Przybylski A
    Acta Haematol Pol; 1991; 22(1):92-9. PubMed ID: 1823972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of blocking antibody in non-inhibitor haemophilic plasma.
    Pool J; Kaelin AC
    Thromb Haemost; 1977 Oct; 38(3):717-20. PubMed ID: 304261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of factor VIII inhibitors developed after exposure to a pasteurised Dutch concentrate compared to classic inhibitors in hemophilia A.
    Mauser-Bunschoten EP; Rosendaal FR; Nieuwenhuis HK; Roosendaal G; Briët E; van den Berg HM
    Thromb Haemost; 1994 Jun; 71(6):703-6. PubMed ID: 7974335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion support for haemophiliacs.
    Allain JP
    Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A.
    Qian J; Borovok M; Bi L; Kazazian HH; Hoyer LW
    Thromb Haemost; 1999 Feb; 81(2):240-4. PubMed ID: 10063999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of inhibitors in hemophiliacs with reference to the transfusion of blood products (author's transl)].
    Kamiya T
    Rinsho Byori; 1978; 26(4):291-7. PubMed ID: 671775
    [No Abstract]   [Full Text] [Related]  

  • 16. [Factor VIII inhibitor in multitransfused hemophiliacs. A finding of varying therapeutic consequences].
    Ly B; Evensen SA; Stavem P
    Tidsskr Nor Laegeforen; 1977 Apr; 97(12):554-6, 8. PubMed ID: 854906
    [No Abstract]   [Full Text] [Related]  

  • 17. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
    Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
    J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor?
    Baglin T; Beacham E
    Thromb Haemost; 1998 Dec; 80(6):1036-7. PubMed ID: 9869186
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor VIII inhibitors: a continuing problem.
    Hoyer LW
    J Lab Clin Med; 1993 Mar; 121(3):385-7. PubMed ID: 8445287
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM; van Helden PM; Schwarz HP; Hausl C
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.